GlassScriptPhysician profile
Benjamin Aaron Banasiewicz
NPI 1013479922
$1,780.32
in general payments reported to CMS, 2019-2025
18 companies · $779 in 2025
The $779 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $66.78 · 2024: $934 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $398.14 | 2024 | Ova1 |
| Biogen, INC. | $376.39 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $197.36 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $168.98 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $120.37 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $68.44 | 2024-2025 | Veozah |
| Millicent US INC | $67.85 | 2025 | Femlyv, Intrarosa |
| Sumitomo Pharma America, INC. | $67.05 | 2025 | Myfembree |
| Mayne Pharma Commercial LLC | $51.94 | 2024-2025 | |
| Meditrina | $41.22 | 2023-2024 | |
| Hologic Sales and Service, LLC | $39.60 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Geron Corporation | $39.51 | 2025 | Rytelo |
| Sanofi Pasteur INC. | $38.90 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.83 | 2025 | |
| Abbvie INC. | $22.04 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.10 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $16.39 | 2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $16.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Banasiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.